Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/47842
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaşaran M.-
dc.contributor.authorÖztanir M.N.-
dc.contributor.authorÇıftçı O.-
dc.contributor.authorBaşak Türkmen N.-
dc.contributor.authorAkyuva Y.-
dc.contributor.authorÖnder A.-
dc.date.accessioned2023-01-09T21:30:21Z-
dc.date.available2023-01-09T21:30:21Z-
dc.date.issued2022-
dc.identifier.issn1309-4483-
dc.identifier.urihttps://doi.org/10.52142/omujecm.39.2.28-
dc.identifier.urihttps://hdl.handle.net/11499/47842-
dc.description.abstractThe Neuroprotective effect of carvacrol, which has anti-inflammatory and antioxidant effects, on infarcted cerebral tissue is present in literature, but this contribution was not sufficiently clarified in terms of biochemistry. It is aimed to investigate the effect of orally administered carvacrol on plasma and intraparenchymal levels of TBARS, GSH, SOD, CAT, GSH-Px, IL-1?, IL-4, and TNF-? after the formation of global ischemia in cerebral tissue. Four groups were formed, each containing ten Wistar albino rats. After anesthesia and analgesia, bilateral carotid communis arteries of rats in the first two groups were clamped for 15 minutes with aneurysm clips. Oral 50 mg/kg/day carvacrol was administered for 15 days to the first group (I/R+CRV) of these two groups in which cerebral ischemia-reperfusion (I/R) was established. On the other hand, %0,01 carboxymethylcellulose (CMC), which is a solvent of carvacrol, at a same volume of first group was administered orally for the same duration to the other group in which also I/R was established (I/R+CMC). In the other two groups in which ischemia was not induced, only carotid artery dissections were made and sutured again. In these two groups, 50 mg/kg/day of carvacrol was administered to the first group (CRV). The Same dose of CMC was administered to the second group (control group). After all these treatments, plasma was collected, and brain tissue was dissected from all groups at the end of the 15th day. Carvacrol can be included in the possible treatment regimen of cerebral stroke with the help of other studies that can be supported on this topic. © 2022 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcarvacrolen_US
dc.subjectCATen_US
dc.subjectCMCen_US
dc.subjectGSHen_US
dc.subjectGSH-Pxen_US
dc.subjectIL-1?en_US
dc.subjectIL-4en_US
dc.subjectischemia reperfusionen_US
dc.subjectSODen_US
dc.subjectTBARSen_US
dc.subjectTNF-?en_US
dc.subjectcarboxymethylcelluloseen_US
dc.subjectcarvacrolen_US
dc.subjectcatalaseen_US
dc.subjectglutathioneen_US
dc.subjectinterleukin 1betaen_US
dc.subjectinterleukin 4en_US
dc.subjectsuperoxide dismutaseen_US
dc.subjectthiobarbituric acid reactive substanceen_US
dc.subjecttumor necrosis factoren_US
dc.subjectanimal experimenten_US
dc.subjectanimal modelen_US
dc.subjectanimal tissueen_US
dc.subjectantiinflammatory activityen_US
dc.subjectantioxidant activityen_US
dc.subjectArticleen_US
dc.subjectcarotid artery injuryen_US
dc.subjectcerebral ischemia reperfusion injuryen_US
dc.subjectcontrolled studyen_US
dc.subjectdrug effecten_US
dc.subjectexperimental cerebral ischemiaen_US
dc.subjectmaleen_US
dc.subjectneuroprotectionen_US
dc.subjectnonhumanen_US
dc.subjectraten_US
dc.subjectrat modelen_US
dc.titleNeuroprotective effect of carvacrol in an experimental cerebral ischemia and reperfusion rat modelen_US
dc.typeArticleen_US
dc.identifier.volume39en_US
dc.identifier.issue2en_US
dc.identifier.startpage454en_US
dc.identifier.endpage458en_US
dc.identifier.doi10.52142/omujecm.39.2.28-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid57967795300-
dc.authorscopusid56033953500-
dc.authorscopusid27867577100-
dc.authorscopusid57208011277-
dc.authorscopusid56033997900-
dc.authorscopusid6603710997-
dc.identifier.scopus2-s2.0-85142061949en_US
dc.identifier.scopusqualityQ4-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
Files in This Item:
File SizeFormat 
Neuroprotective effect of carvacrol.pdf619.11 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

1
checked on Jun 29, 2024

Page view(s)

42
checked on May 27, 2024

Download(s)

10
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.